13 / 38
SOMATOSTATIN ANALOGS
TIME OF SSA TREATMENT INITIATION & LONG TERM SURVIVAL
Crossover from placebo to octreotide LAR in
88.4% after median time of 9.2 months (2-82)
Caplin M, et al. Endocrine-Related Cancer 2016; 23:191-199
Rinke A, et al. Neuroendocrinology 2017;104:26–32
Estimated mPFS LAN-LAN = 32,8 m
Estimated mPFS PBO-LAN =14,0 m